CAR T-cell therapy:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Abingdon
Karger
2021
|
| Schriftenreihe: | Fast facts
|
| Schlagworte: | |
| Online-Zugang: | DE-19 Volltext |
| Beschreibung: | 1 Online-Ressource Illustrationen |
| ISBN: | 9783318067422 3318067423 |
| DOI: | 10.1159/isbn.978-3-318-06742-2 |
Internformat
MARC
| LEADER | 00000nam a22000008c 4500 | ||
|---|---|---|---|
| 001 | BV047711319 | ||
| 003 | DE-604 | ||
| 005 | 20241218 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220126s2021 sz a||| o|||| 00||| eng d | ||
| 015 | |a 21,N01 |2 dnb | ||
| 020 | |a 9783318067422 |9 978-3-318-06742-2 | ||
| 020 | |a 3318067423 |q (electronic bk.) |9 3318067423 | ||
| 024 | 7 | |a 10.1159/isbn.978-3-318-06742-2 |2 doi | |
| 024 | 3 | |a 9783318067415 | |
| 035 | |a (OCoLC)1294734875 | ||
| 035 | |a (DE-599)BVBBV047711319 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a sz |c CH | ||
| 049 | |a DE-19 |a DE-355 |a DE-384 | ||
| 100 | 1 | |a Buka, Richard J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a CAR T-cell therapy |c Richard J. Buka, Ankit J Kansagra |
| 246 | 1 | 3 | |a Fast facts: CAR T-cell therapy |
| 246 | 1 | 3 | |a Chimeric antigen receptor T cell therapy |
| 246 | 1 | 3 | |a CAR T-cell therapy - insight into current and future applications |
| 264 | 1 | |a Abingdon |b Karger |c 2021 | |
| 300 | |a 1 Online-Ressource |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Fast facts | |
| 650 | 0 | 7 | |a T-Lymphozyt |0 (DE-588)4127387-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 653 | |a Oncology | ||
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 0 | 2 | |a T-Lymphozyt |0 (DE-588)4127387-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Kansagra, Ankit J. |e Verfasser |4 aut | |
| 710 | 2 | |a S. Karger GmbH |0 (DE-588)1064784445 |4 pbl | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-318-06741-5 |
| 856 | 4 | 0 | |u https://doi.org/10.1159/isbn.978-3-318-06742-2 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ZDB-25-KFF | ||
| 912 | |a ZDB-4-EOAC | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033095078 | |
| 966 | e | |u https://doi.org/10.1159/isbn.978-3-318-06742-2 |l DE-19 |p ZDB-25-KFF |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818768221046571008 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Buka, Richard J. Kansagra, Ankit J. |
| author_facet | Buka, Richard J. Kansagra, Ankit J. |
| author_role | aut aut |
| author_sort | Buka, Richard J. |
| author_variant | r j b rj rjb a j k aj ajk |
| building | Verbundindex |
| bvnumber | BV047711319 |
| collection | ZDB-25-KFF ZDB-4-EOAC |
| ctrlnum | (OCoLC)1294734875 (DE-599)BVBBV047711319 |
| doi_str_mv | 10.1159/isbn.978-3-318-06742-2 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a22000008c 4500</leader><controlfield tag="001">BV047711319</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20241218</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220126s2021 sz a||| o|||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,N01</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783318067422</subfield><subfield code="9">978-3-318-06742-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3318067423</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">3318067423</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1159/isbn.978-3-318-06742-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783318067415</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1294734875</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047711319</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">sz</subfield><subfield code="c">CH</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-384</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Buka, Richard J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">CAR T-cell therapy</subfield><subfield code="c">Richard J. Buka, Ankit J Kansagra</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Fast facts: CAR T-cell therapy</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Chimeric antigen receptor T cell therapy</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">CAR T-cell therapy - insight into current and future applications</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Abingdon</subfield><subfield code="b">Karger</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Fast facts</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">T-Lymphozyt</subfield><subfield code="0">(DE-588)4127387-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">T-Lymphozyt</subfield><subfield code="0">(DE-588)4127387-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kansagra, Ankit J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">S. Karger GmbH</subfield><subfield code="0">(DE-588)1064784445</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-318-06741-5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1159/isbn.978-3-318-06742-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-25-KFF</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EOAC</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033095078</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1159/isbn.978-3-318-06742-2</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-25-KFF</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047711319 |
| illustrated | Illustrated |
| index_date | 2024-07-03T19:00:47Z |
| indexdate | 2024-12-18T09:02:19Z |
| institution | BVB |
| institution_GND | (DE-588)1064784445 |
| isbn | 9783318067422 3318067423 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033095078 |
| oclc_num | 1294734875 |
| open_access_boolean | 1 |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-384 |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-384 |
| physical | 1 Online-Ressource Illustrationen |
| psigel | ZDB-25-KFF ZDB-4-EOAC |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Karger |
| record_format | marc |
| series2 | Fast facts |
| spelling | Buka, Richard J. Verfasser aut CAR T-cell therapy Richard J. Buka, Ankit J Kansagra Fast facts: CAR T-cell therapy Chimeric antigen receptor T cell therapy CAR T-cell therapy - insight into current and future applications Abingdon Karger 2021 1 Online-Ressource Illustrationen txt rdacontent c rdamedia cr rdacarrier Fast facts T-Lymphozyt (DE-588)4127387-4 gnd rswk-swf Immuntherapie (DE-588)4026640-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Oncology Krebs Medizin (DE-588)4073781-0 s Immuntherapie (DE-588)4026640-0 s T-Lymphozyt (DE-588)4127387-4 s DE-604 Kansagra, Ankit J. Verfasser aut S. Karger GmbH (DE-588)1064784445 pbl Erscheint auch als Druck-Ausgabe 978-3-318-06741-5 https://doi.org/10.1159/isbn.978-3-318-06742-2 Verlag kostenfrei Volltext |
| spellingShingle | Buka, Richard J. Kansagra, Ankit J. CAR T-cell therapy T-Lymphozyt (DE-588)4127387-4 gnd Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4127387-4 (DE-588)4026640-0 (DE-588)4073781-0 |
| title | CAR T-cell therapy |
| title_alt | Fast facts: CAR T-cell therapy Chimeric antigen receptor T cell therapy CAR T-cell therapy - insight into current and future applications |
| title_auth | CAR T-cell therapy |
| title_exact_search | CAR T-cell therapy |
| title_exact_search_txtP | CAR T-cell therapy |
| title_full | CAR T-cell therapy Richard J. Buka, Ankit J Kansagra |
| title_fullStr | CAR T-cell therapy Richard J. Buka, Ankit J Kansagra |
| title_full_unstemmed | CAR T-cell therapy Richard J. Buka, Ankit J Kansagra |
| title_short | CAR T-cell therapy |
| title_sort | car t cell therapy |
| topic | T-Lymphozyt (DE-588)4127387-4 gnd Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | T-Lymphozyt Immuntherapie Krebs Medizin |
| url | https://doi.org/10.1159/isbn.978-3-318-06742-2 |
| work_keys_str_mv | AT bukarichardj cartcelltherapy AT kansagraankitj cartcelltherapy AT skargergmbh cartcelltherapy AT bukarichardj fastfactscartcelltherapy AT kansagraankitj fastfactscartcelltherapy AT skargergmbh fastfactscartcelltherapy AT bukarichardj chimericantigenreceptortcelltherapy AT kansagraankitj chimericantigenreceptortcelltherapy AT skargergmbh chimericantigenreceptortcelltherapy AT bukarichardj cartcelltherapyinsightintocurrentandfutureapplications AT kansagraankitj cartcelltherapyinsightintocurrentandfutureapplications AT skargergmbh cartcelltherapyinsightintocurrentandfutureapplications |